Table 2.
Pathological and Volumetry Result of Patients
| Pathological/Volumetry Index | Number (%) / Average±SD |
|---|---|
| pT Stage | |
| ypT0 | 5 (6.2%) |
| ypT1-2 | 23 (28.8%) |
| ypT3 | 51 (63.8%) |
| ypT4 | 1 (1.2%) |
| pN Stage | |
| ypN0 | 61 (76.3%) |
| ypN1 | 9 (11.3%) |
| ypN2 | 10 (12.4%) |
| pTNM Stage | |
| pCR | 5 (6.3%) |
| Stage I | 20 (25.0%) |
| Stage II | 36 (45.0%) |
| Stage III | 19 (23.7%) |
| Lymphovascular Invasion | |
| Yes | 3 (3.7%) |
| No | 77 (96.3%) |
| Perineural Invasion | |
| Yes | 9 (11.3%) |
| No | 71 (88.7%) |
| Extra Nodal Tumor Deposits | |
| Yes | 9 (11.3%) |
| No | 71 (88.7%) |
| CRM | |
| ≤1 mm | 1 (1.2%) |
| >1 mm | 71 (98.8%) |
| VPre-Therapy (cm3) | 35.0±38.7 |
| VPost-Therapy (cm3) | 16.5±16.2 |
| TVRR (%) | 51.7±25.1 |
| T Downstage | |
| Yes | 24 (30.0%) |
| No | 56 (70.0%) |
| N Downstage | |
| Yes | 43 (53.8%) |
| No | 37 (46.2%) |
| Overall Downstage | |
| Yes | 25 (31.2%) |
| No | 55 (68.8%) |
| TRG | |
| 0 | 5 (6.3%) |
| 1 | 20 (25.0%) |
| 2 | 30 (37.5%) |
| 3 | 25 (31.2%) |